EUVIMEDEUVIMED entdecken
Fallbericht

Very-Early-Onset Treatment-Refractory Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy Responsive to Multimodal Therapy

Hoda Y Tomoum iD, Dalia M El-Mikkawy iD, Rasha H El-Owaidy iD, Amro M Stino

Journal of Child Neurology · 2025

DOI: 10.1177/08830738251382563 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Child Neurology, 2025. Verfasst von Hoda Y Tomoum und 3 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Neurology Unit, Children's Hospital, Ain Shams University, Cairo, Egypt. Hauptthemen laut MEDLINE: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating, Plasma Exchange. Die Arbeit nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic inflammatory demyelinating polyradiculoneuropathy is a treatable pediatric polyneuropathy, with both a typical form and variants. The approach to treatment-refractory chronic inflammatory demyelinating polyradiculoneuropathy is not fully characterized, especially in children with very-early-onset chronic inflammatory demyelinating polyradiculoneuropathy, namely, those with symptom onset before 4 years of age. We herein report the case of a 30-month-old child with treatment-refractory, very-early-onset chronic inflammatory demyelinating polyradiculoneuropathy who failed to respond to initial intravenous immunoglobulin and then corticosteroid monotherapy. He was ultimately switched to combined pulsed intravenous methylprednisolone and plasma exchange, followed by induction and maintenance rituximab therapy. The patient exhibited a significant and sustained clinical response to this regimen.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polyradiculoneuropathy, Chronic Inflammatory DemyelinatingPlasma ExchangeHumansMaleChild, PreschoolCombined Modality TherapyMethylprednisoloneRituximabImmunologic FactorsImmunoglobulins, IntravenousTreatment Outcome

Stichwörter der Autor:innen

pediatric CIDPplasma exchangerituximabtreatment refractory CIDPvery-early-onset CIDP

Substanzen

MethylprednisoloneRituximabImmunologic FactorsImmunoglobulins, Intravenous

Autor:innen und Institutionen

  • Pediatric Neurology Unit, Children's Hospital, Ain Shams University, Cairo, Egypt.
  • Department of Physical Medicine, Rheumatology and Rehabilitation, Ain Shams University, Cairo, Egypt.
  • Pediatric Allergy, Immunology and Rheumatology Unit, Children's Hospital, Ain Shams University, Cairo, Egypt.
  • Department of Neurology, University of Michigan, Ann Arbor, MI, USA.

ORCID-Profile: Hoda Y Tomoum, Dalia M El-Mikkawy, Rasha H El-Owaidy

Zitieren

APA

Tomoum, H. Y., El-Mikkawy, D. M., El-Owaidy, R. H., & Stino, A. M. (2025). Very-Early-Onset Treatment-Refractory Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy Responsive to Multimodal Therapy. Journal of Child Neurology. https://doi.org/10.1177/08830738251382563

Vancouver

Tomoum HY, El-Mikkawy DM, El-Owaidy RH, Stino AM. Very-Early-Onset Treatment-Refractory Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy Responsive to Multimodal Therapy. Journal of Child Neurology. 2025. doi:10.1177/08830738251382563

BibTeX
@article{Tomoum2025,
  author = {Tomoum, Hoda Y and El-Mikkawy, Dalia M and El-Owaidy, Rasha H and Stino, Amro M},
  title = {Very-Early-Onset Treatment-Refractory Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy Responsive to Multimodal Therapy},
  journal = {Journal of Child Neurology},
  year = {2025},
  doi = {10.1177/08830738251382563}
}
Kostenlos starten →